Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 16.
Published in final edited form as: Mol Cell. 2023 Mar 16;83(6):877–889. doi: 10.1016/j.molcel.2023.02.016

Metabolic sensing and control in mitochondria

Yuyang Liu 1, Kıvanç Birsoy 1,*
PMCID: PMC10332353  NIHMSID: NIHMS1881274  PMID: 36931256

SUMMARY:

Mitochondria are membrane-enclosed organelles with endosymbiotic origins, harboring independent genomes and a unique biochemical reaction network. To perform their critical functions, mitochondria must maintain a distinct biochemical environment and coordinate with cytosolic metabolic networks of the host cell. This coordination requires them to sense and control metabolites and respond to metabolic stresses. Indeed, mitochondria adopt feedback or feedforward control strategies to restrain metabolic toxicity, enable metabolic conservation, ensure stable levels of key metabolites, allow metabolic plasticity and prevent futile cycles. A diverse panel of metabolic sensors mediates these regulatory circuits, whose malfunctioning leads to inborn errors of metabolism with mild to severe clinical manifestations. In this review, we discuss the logic and molecular basis of metabolic sensing and control in mitochondria. The past research outlined recurring patterns in mitochondrial metabolic sensing and control and highlighted key knowledge gaps in this organelle that are potentially addressable with emerging technological breakthroughs.

Summary

Mitochondria engage both feedback and feedforward control circuits to achieve the robust regulation of metabolism. A diverse array of molecular sensors monitors metabolite levels and fine-tunes enzymatic activities, ensuring swift adaptation to metabolic demand and effective protection against stress.


Mitochondria are essential organelles in all higher eukaryotes, supporting growth and viability through ATP production, biosynthesis and signaling functions. It is widely believed that mitochondria emerged during the early evolutionary history of eukaryotes from endosymbiotic alphaproteobacteria1. The transition from an autonomous, facultatively aerobic pre-mitochondrial alphaproteobacterium to a permanently integrated organelle involves extensive integration of genomes, the evolution of protein and metabolite transport machinery, and coordination of metabolism between the endosymbiont and the host cell2. These processes enable the formation of a distinct metabolic environment inside the mitochondria, which is critical for their proper functioning.

Central to metabolic compartmentalization is a highly regulated biochemical interface consisting of a selectively permeable mitochondrial inner membrane, dedicated metabolite transporters and asymmetrically distributed enzymes for the generation of chemical gradients. While it provides the cell improved metabolic versatility, rapid metabolic control and protection against toxic intermediates3, maintaining metabolic compartmentalization in mitochondria comes with its unique challenges. From a host cell-centric point of view, the host-mitochondria interface resembles a black-box computer program. For input, it accepts signals from the host reflecting the cellular nutrient and energetics status and metabolic demands; for output, it generates a two-pronged effect on cellular physiology: a metabolic output, including the consumption and production of metabolites; and a signaling output, transmitting metabolic stress, and malfunction sensed by the mitochondria that warrant additional responses by the host cell. Thus, functioning mitochondria must a) swiftly respond to the metabolic demands of the cell, b) generate proper metabolic output by producing an appropriate amount of energy and biosynthetic precursors and c) initiate correct signaling response that adequately reflects metabolic abnormalities encountered by the mitochondria. Any breach of these functional guardrails often triggers the adaptive response of the host to clear defective mitochondria via selective mitophagy or programmed cell death4,5.

Sensing mechanisms for cellular metabolites have been documented for both prokaryotes and eukaryotes6,7. This includes members of the alphaproteobacteria and Asgardarchaeota taxa8,9, lineages that were predicted to give rise to modern eukaryotes and mitochondria. These mechanisms couple nutrient availability to not only the metabolic network but also translation and transcriptional machinery. While the mitochondria resemble their ancestors by maintaining an independent genome and a dedicated system for transcription and translation, there remains a knowledge gap on how mitochondria employ metabolic sensing and control mechanisms to fulfill their physiological functions. Previous research has highlighted some recurring themes in mitochondrial metabolic control. As discussed below, these principles underlie the wiring of the mitochondrial metabolic network and may inform future studies on unrecognized mechanisms for mitochondrial metabolic sensing and control.

Two strategies of mitochondrial metabolic control: homeostasis and adaptation

Like all biological systems, mitochondria must respond to changes in resources and adjust their metabolism accordingly. A unique feature of mitochondria is that their biochemical environment is already highly regulated by the host cell. This nested structure implies that an intracellular compartment could maintain a relatively stable internal environment by relying solely on the equilibration of metabolite transport. Therefore, mechanisms dedicated to mitochondrial metabolic sensing and control must serve a broader function beyond the homeostasis of intramitochondrial metabolites. As discussed below, requirements for metabolic sensing and control are derived from many aspects of mitochondrial function. Mitochondria are biosynthetic organelles whose output (such as the redox-active heme cofactor) may require tight regulation. They are also metabolically plastic and may adjust their metabolic pattern according to cellular demand. Additionally, some of the mitochondrial processes may have a stringent requirements for the internal environment distinct from the cytosol; for example, iron concentration in mitochondria is significantly higher10, likely in support of the assembly of iron-sulfur clusters. Finally, mitochondria are specifically the source or target of unique metabolic stresses. These features raise the possibility that metabolic sensing and control mechanisms that closely interact with mitochondria must be present to instruct the organellar function.

These functional necessities demand different logic for metabolite sensing. Mitochondria require a wide range of metabolic parameters to be sensed and processed to instruct the regulation of metabolic responses. While cellular parameters such as pH, osmotic pressure and cholesterol levels, could be sensed and controlled within a relatively narrow range, others (i.e. availability of oxygen and a subset of nutrients11) are extrinsic in nature and cannot be regulated within an optimal range. Thus, metabolic processes reliant on these parameters need to be adjusted to prioritize the most essential physiological functions. Accordingly, we propose that mitochondria adopt two distinct circuits of metabolic control—feedforward and feedback control—to achieve either metabolic homeostasis or metabolic adaptation in response to these perturbations. These two strategies differ mainly in the coupling pattern between metabolic sensing and downstream effects. As elegantly reviewed by Ye and Medzhitov12, both circuits require “sensors” that respond to metabolic perturbations, while only in feedback control circuits, the system exerts a direct effect on the sensed metabolic parameter retroactively. Oftentimes, changes in the “input” metabolic parameter stimulate a response in the system that counteracts such perturbation via a negative feedback mechanism. This circuit is instrumental for controlling the levels of metabolites within a narrow range for optimal physiological function. On the other hand, the feedforward control mechanism lacks such a homeostatic effector that attenuates perturbation; rather, it rewires the metabolic network to ensure adequate metabolic output in the presence of such perturbation. In some scenarios, these two circuits could act simultaneously, engaging downstream effector that both maintains homeostatic control and promotes adaptive response. For example, mitochondria-derived heme is sensed by the transcriptional repressor BTB Domain And CNC Homolog 1 (BACH1), which upon binding to heme derepresses the expression of the heme-degrading enzyme heme oxygenase-113 in a classic feedback regulation mechanism. At the same time, Bach1 target genes also include redox regulators and iron storage proteins14 that mediate an adaptive response to increased iron released from heme degradation, thus forming an adaptive feedforward circuit. In mitochondria, metabolite sensing mechanisms engage both feedback and feedforward regulations, ensuring a proper mitochondrial internal environment and swift adaptation to cellular demand.

Mitochondria achieve homeostatic control of metabolism through feedback regulation

Feedback regulation is critical for effective metabolic regulation since it allows the metabolic flux to dynamically respond to demand while maintaining metabolite levels far from thermodynamic equilibrium15. This typically involves a sensing mechanism that responds to a perturbation in metabolic parameters and an effector to dampen the response. Without feedback inhibition, most enzymatic reactions would not swiftly adjust the metabolic flux in response to fluctuating demand. For mitochondrial metabolism, this feature is particularly desirable for restraining the toxicity of metabolite intermediates or avoiding resource-wasting through the synthesis of low-demand metabolites.

A. Feedback regulation restrains toxicity of mitochondria-produced metabolites

The metabolic versatility of mitochondria has made it an ideal compartment for the biosynthesis of not only building blocks for cell growth but also diverse cofactors and signaling molecules. These metabolites, while serving critical roles in biochemical catalysis or stress responses, often display intrinsic toxicity when produced at elevated levels. Therefore, mechanisms have evolved to limit their production and prevent excessive damage to mitochondrial functions. Given that many of these metabolites are produced via enzymatic actions within the mitochondrial matrix, the compartmentalization of their synthesis allows multiple layers of regulation, via tuning substrate import and export as well as enzyme expression, localization and activity. For example, itaconate is an important regulator of innate immunity produced primarily by myeloid cells during activation1618. The enzyme responsible for itaconate synthesis, ACOD1, resides in mitochondrial matrix19; once produced, itaconate exerts its anti-inflammatory effects partially by acting as a competitive inhibitor of succinate dehydrogenase. Additionally, as an electrophilic metabolite, itaconate alkylates thiol groups on target proteins such as Nuclear factor erythroid 2–related factor 2 (Nrf2) and triggers electrophile stress response20. As an unrestrained electrophilic attack on thiolcontaining proteins is likely to disrupt cellular physiology, multiple downstream targets of itaconate function to restrain its overproduction or increase cellular buffering capacity against electrophilic stress. Nrf2 activation by itaconate leads to increased production of glutathione, a small molecule thiol that serves as the primary buffer against electrophiles and reduces itaconate content by forming adducts through its thiol group. It has also been proposed that itaconate modifies and inhibits the activity of mitochondrial isocitrate dehydrogenase (IDH2), therefore restraining the production of itaconate itself by reducing the supply of its precursor, isocitrate, via reductive carboxylation21.

Another interesting example of such regulation is the synthesis of heme, an essential cofactor produced via a multistep pathway that spans across the mitochondria and the cytosol. Despite the critical function of heme, free heme can participate in Fenton reactions that generate highly toxic hydroxyl radicals, which damage proteins and lipids and must therefore be tightly regulated22. In eukaryotes, control of heme synthesis occurs primarily at its rate-limiting enzyme, delta-aminolevulinate synthase (encoded by ubiquitously expressed ALAS1 and erythroid-restricted ALAS2). Multiple mechanisms act in concert to repress ALAS activity in response to heme accumulation. Heme suppresses ALAS1 levels by inhibiting the translation and enhancing the degradation of its mRNA23,24. Moreover, heme binds ALAS1 via Cys-Pro motifs25, inhibiting its mitochondrial import26 and inducing the degradation of the protein via the mitochondrial protease CLPP/CLPX. These mechanisms ensure that free heme, as well as phototoxic porphyrin intermediates, are kept at a level that does not interfere with normal cellular physiology. Failure in the metabolic control for heme synthesis leads to porphyria, a family of conditions caused by the accumulation of toxic heme synthesis intermediates that damage the liver, kidney and nervous system27. Loss-of-function mutations in multiple enzymes of the heme synthesis pathway have been found to cause porphyria, due to ineffective feedback inhibition on the rate-limiting enzyme ALAS. Much of the clinical symptoms could be attributed to intermediate toxicity rather than insufficient heme production, as demonstrated by several cases of liver transplantation from donors with porphyria28. Such clinical observations highlight the essential functions of these feedback mechanisms in limiting the metabolite toxicity by maintaining the intermediates within the range required for normal and mitochondrial functions.

B. Feedback regulation enables the conservation of metabolites consumed in mitochondria

Feedback metabolic control in mitochondria also contributes to metabolic efficiency by restricting the production of metabolites required at a stable, but relatively low levels. Without feedback regulation, producing such metabolites at a near-equilibrium rate would consume an unnecessarily large amount of energy or biosynthetic precursors. For example, coenzyme A is an essential cofactor for delivering acetyl and acyl groups in mitochondria. Synthesis of coenzyme A starts with Pantothenate kinase isozymes, among which PANK2 is predicted to localize in mitochondrial intermembrane space29,30. This highly conserved pathway consumes four ATP molecules and cysteine per molecule of coenzyme A. Intracellular concentration of CoA species is estimated to be at low micromolar levels in the cytosol and millimolar levels in mitochondria31, and because CoA is used catalytically in most reactions, the demand to replenish CoA pool is likely modest, as suggested by the relatively long turnover time of CoA in mouse tissues compared to other cofactors32,33. Thus, it may be desirable to limit the production of coenzyme A once its biological demand is satisfied. This is achieved through a common feature of all PANK enzymes: from E.coli to mammalian cells, these enzymes are all allosterically inhibited by CoASH, acyl and acetyl CoA34,35. The high conservation of this regulatory mechanism likely suggests a significant fitness benefit for keeping CoA synthesis in check. Importantly, although PANK isozymes are also present in the cytosol, mutations in the mitochondrial PANK2 isoform led to Pantothenate kinase-associated neurodegeneration (PKAN), indicating that mitochondrial localized, regulated production of Coenzyme A serves a unique physiological function.

C. Feedback regulation ensures robust homeostatic control of metabolite levels in mitochondria

In principle, mitochondria could utilize feedback control mechanisms to achieve a stable chemical environment, particularly for metabolites that are synthesized or utilized only in mitochondria, or for metabolites that require stable mitochondrial concentrations. Similar mechanisms for regulating redox potential or pH have been reported for other organelles36,37, but relevant studies for mitochondrial metabolites are scarce. One example is the synthesis of cardiolipin, the lipid species with exclusively mitochondrial distribution. The enzymatic pathway for cardiolipin synthesis resides primarily on the inner membrane of mitochondria, while its precursor phosphatidic acid (PA) needs to be transferred from the endoplasmic reticulum and the outer membrane by lipid transport proteins38. Intriguingly, in S. cerevisiae, transport of PA between the inner and outer membrane by Ups1 is subjected to feedback regulation by cardiolipin itself. Accumulation of cardiolipin in the mitochondrial inner membrane traps Ups1 and limits its shuttling between membranes, effectively shutting down the inflow of PA to the cardiolipin synthesis pathway39. This elegant mechanism likely functions to control the levels of cardiolipin in the mitochondrial inner membrane near its optimal range. Given the unique chemical structure of cardiolipin, such a regulatory mechanism is essential for the structural and functional integrity of mitochondria.

A comparable example is glutathione homeostasis in mitochondria. It has been long observed that following systemic inhibition of glutathione synthesis, the decline in mitochondrial glutathione levels displays much slower kinetics compared to cytosolic glutathione40. It appears that the mitochondrial transport for glutathione is wired in a way that prioritizes the maintenance of the mitochondrial glutathione pool over the cytosolic pool. Recent studies have identified SLC25A39/SLC25A40 as candidates for mitochondrial glutathione importers41,42. Remarkably, SLC25A39 displays a classic feedback regulation behavior as it accumulates dramatically upon pharmacological inhibition of glutathione synthesis41. Although the molecular mechanism remains elusive, these observations hint at the intriguing possibility that SLC25A39 may be part of the machinery that maintains mitochondrial glutathione levels via a feedback homeostatic mechanism. The SLC25 mitochondrial transporter family plays a pivotal role in shaping intramitochondrial metabolite pools43; since it contains many members with unannotated functions, it is likely that many of them participate in homeostatic regulation via unappreciated regulatory circuits.

Mitochondria adapt to metabolic perturbations through feedforward regulation

Although a recurring theme in metabolic regulation, homeostatic control via feedback regulation is not sufficient for the optimal functioning of mitochondrial metabolism. This is particularly relevant for perturbations and stresses that are exogenous in nature, such as physical and chemical stresses, or stochastically occurring damage of organelles. Regulatory mechanisms in these scenarios typically function as feedforward circuits that drive an adaptive response from the cell. Similar to feedback regulation, these mechanisms involve sensing of metabolic cues but do not maintain homeostatic levels of a given metabolite under perturbations. Instead, mitochondria rely on these mechanisms to ensure efficient utilization of resources while these perturbations persist.

A. Feedforward regulation allows metabolic plasticity of mitochondria

Mitochondria display remarkable metabolic plasticity that funnels biochemical intermediates into divergent fates under different metabolic states. This is achieved via tight coupling between metabolic sensing mechanisms and enzymatic activities, best exemplified by the regulation of the urea cycle. As urea production is essential for the clearance of nitrogen-containing metabolic waste, organisms must dynamically respond to the demand of protein catabolism44,45, which fluctuates with food uptake and cannot be physiologically maintained within a narrow range. Therefore, a set of feedforward regulatory mechanisms has evolved to adjust the flux through the urea cycle in response to the demand for nitrogen waste disposal. Mitochondria harbors the rate-limiting enzyme of the urea cycle Carbamoyl phosphate synthetase I (CPS1), where nitrogen enters the urea cycle in the form of ammonia. First, this enzyme is regulated by an obligate allosteric activator, N-acetylglutamate46, a metabolite produced in the mitochondria by N-acetylglutamate synthase (NAGS)47,48. Arginine, an intermediate of the urea cycle, stimulates the activity of NAGS and leads to the higher activity of the urea cycle47. Together, these mechanisms allow the urea cycle activity to respond to fluctuations in ammonia at enhanced sensitivity for its efficient clearance. Notably, NAGS mutations that abolish the stimulatory effect of arginine49 cause late-onset hyperammonemia49. Much of this regulatory mechanism is spatially constrained in the mitochondria, which creates a dedicated compartment for the accumulation of N-acetylglutamate and its allosteric regulation of CPS1 activity. Since N-acetylglutamate is produced in the mitochondria and degraded in the cytosol50, compartmentalization allows an additional layer of regulation. Indeed, it has been suggested that glucagon increases mitochondrial N-acetylglutamate levels potentially by inhibiting its mitochondrial efflux51,52, a poorly understood mechanism. These findings suggest that the confinement of CPS1 and its allosteric activator N-acetylglutamate in the mitochondrial matrix is critical for effective control of urea cycle activity.

A parallel example of the adaptive activation of a metabolic pathway is the unique molecular feature of PANK2, a mitochondrially-localized enzyme catalyzing the rate-limiting step of coenzyme A synthesis. As described above, all PANK isozymes display feedback inhibition by CoASH and acetyl-CoA, yet PANK2 seems to be highly sensitive to acetyl-CoA. Indeed, under physiological conditions, it is predicted to have minimal catalytic activity53. This paradoxical behavior is resolved by the observation that this inhibition is released in the presence of acylcarnitine, the substrate of beta-oxidation. Since CoA is required for beta-oxidation reactions, the accumulation of acylcarnitine serves as a proxy for CoA limitation, and PANK2 responds to this signal by increasing the supply of CoA precursors, ensuring efficient catabolism of fatty acid chains.

B. Feedforward regulation prevents futile cycles

Substrate cycles, or futile cycles, consist of antiparallel chemical reactions that collectively do not result in the net conversion of substrates to products. These loop reactions could be desirable for processes such as thermogenesis; additionally, they form important nodes of metabolic regulation because a relatively minor change in forward or backward reaction could lead to a significant shift in the directional metabolic flux54. In mitochondria, it was proposed that the forward and reverse reactions catalyzed by NAD+- and NADP+-dependent isocitrate dehydrogenases form a substrate cycle. Electron from reduced NADH is then transferred to NADP+ by nicotinamide nucleotide transhydrogenase (NNT), coupled to proton translocation across the mitochondrial inner membrane55. This mechanism thus allows the finetuning of TCA cycle activity and particularly in response to proton motive force generated by the ETC complexes.

While these substrate cycles afford cells metabolic flexibility, excessive futile cycling needs to be carefully controlled to avoid unnecessary loss of energy. Metabolic compartmentalization by mitochondria provides a structural basis for separating forward and reverse biochemical reactions. Additionally, mechanisms that sense metabolic demands and switch between forward and reverse reactions must be integrated into mitochondrial metabolic networks, ensuring their efficiency and plasticity. These regulatory mechanisms often involve key enzymes at the mitochondria-cytosol interface that restrain the access of substrates to a certain compartment. A classic example is the regulation of β-oxidation and fatty acid biosynthesis via carnitine palmitoyltransferase (CPT1) by malonyl-CoA56. As the entry site of most long-chain fatty acid to β-oxidation, CPT1 activity is allosterically inhibited by the substrate of fatty acid synthesis, malonyl-CoA. When the demand for energy is low, access of the mitochondrial beta-oxidation machinery to fatty acid is limited, as acetyl-CoA is shunted towards malonyl-CoA and blocks fatty acid entry into mitochondria through allosteric inhibition of CPT15759. In contrast, when energy demand is high and AMPK is activated, fatty acid synthesis is shut down by the phosphorylation of acetyl-CoA carboxylase, reducing malonyl-CoA levels and releasing the inhibition on CPT160,61, thereby switching the direction of lipid metabolism to β-oxidation. Futile cycling from simultaneous fatty acid synthesis and catabolism is thus prevented jointly by a) segregating the forward and reverse reactions by the mitochondrial inner membrane and b) excluding the substrate access to compartmentalized enzymes when the opposite reaction is proceeding.

C. Feedforward regulation enables adaptive responses to extrinsic metabolic stress

The structural complexity of mitochondrial metabolic machinery dictates that numerous forms of biological stress could significantly limit its functioning. Cells must initiate appropriate responses to adapt to these environmental perturbations ranging from nutrient and oxygen deprivation to noxious chemical stimuli and infection. Mechanisms for metabolic regulation under these scenarios are akin to feedforward regulation illustrated above and typically trigger downstream effectors that systematically shift the metabolic status of the cell in response to mitochondria-derived stress.

Mitochondria dysfunction triggers the integrated stress response (ISR) and suppresses the mechanistic Target Of Rapamycin Complex 1 (mTORC1) activity, turning down the synthetic pathways for proteins and other building blocks as an adaptation to resource limitation. These pathways are wired in a fashion that senses functional defects triggered by diverse metabolic stresses. Short-term blockade of the mitochondrial electron transport chain activates AMP-activated protein kinase (AMPK) and acutely suppresses mTOR1 signaling, likely via sensing of decreased ATP/AMP ratio62. Extended inhibition of the mitochondrial electron transport chain, which disrupts membrane potential-coupled protein import, engages the integrated stress response via a mitochondrial matrix-targeted protein DAP3 binding cell death enhancer 1 (DELE1)63,64, which is normally processed in the mitochondrial matrix but gets cleaved by the metalloendopeptidase OMA1 in the intermembrane space when its import is inhibited65. Cleaved DELE1 triggers the integrated stress response by activating the eukaryotic translation initiation factor 2A (eIF2a) kinase heme-regulated inhibitor (HRI). Through a parallel mechanism, stresses that perturb the integrity of the mitochondrial outer membrane engage HRI to activate the integrated stress response via the release of cytochrome C from the intermembrane space66. Expression of stress response genes downstream of ISR effector activating transcription factor 4 (ATF4) consequently enable adaptation to metabolic stress. In all these cases, the metabolic compartmentalization of mitochondria is instrumental for stress sensing and metabolic control. The general principle is that these compartments create segregated spaces for sequestering signaling components that are susceptible to perturbations. The compromised integrity of these compartments leads to the mislocalization of signaling components, which are interpreted by the cell as a proxy for metabolic stress. Interestingly, this paradigm is adopted by cells to clear defective mitochondria via selective mitophagy5, respond to mitochondrial damage by sensing mitochondrial DNA via the cyclic GMP–AMP synthase (cGAS)- stimulator of interferon genes (STING) pathway, and adapt to protein misfolding stress in the mitochondrial by activating transcription factor associated with stress (ATFS1)-mediated mitochondrial unfolded protein response (mtUPR) pathway67. Regulation and functions of these pathways have been extensively discussed before5,67,68.

Molecular basis of mitochondrial metabolic sensing

In metabolic control, the term “sensor” could be loosely interpreted to encompass any protein that a) physically associates with a metabolite or its derivative and b) changes its behavior according to the varying levels of that metabolite within its physiological range. This definition does not preclude the existence of additional sensing mechanisms that do not directly involve a protein component or protein-metabolite interaction (RNA-based riboswitches are classic examples)69; but even this narrower category of metabolic sensors contains remarkable mechanistic diversity. The segregation of the metabolite pool of the mitochondrial matrix by the mitochondrial inner membrane plays a central role in metabolic sensing and control3. As specified below, this barrier serves as a structural basis for maintaining a distinct biochemical environment and restrains futile cycling by physically segregating antiparallel reactions. It restricts the access of reactive or toxic metabolites to the cytosol, enabling robust regulation of their production while limiting potential damage of cellular components. It also creates gradients of proton and electromotive force and allows the sequestration of signaling molecules such as cytochrome C and DELE1; upon metabolic stress that disrupts the integrity of this barrier, the release of these factors could be sensed as proxies for metabolic stress. Many of the sensing mechanisms described here either rely upon the intact mitochondria-cytosol barrier for robust activation or indirectly sense the defects of this barrier itself. We hereby describe four molecular mechanisms recurrently observed in mitochondrial metabolic control.

A. Sensing metabolites via allosteric regulation of mitochondrial enzymes

One of the most common mechanisms for metabolite sensing is the allosteric regulation of mitochondrial enzymes and transporters, allowing rapid tuning of biochemical fluxes in response to diverse metabolic cues70. Factors sensed via allosteric regulation range from amino acids, lipids, carbohydrates and metabolic intermediates to metals and cofactors; in many cases, it allows the integration of multiple metabolic signals via the activity of a single enzyme. A well-studied example is the regulation of glutamate dehydrogenase (GDH) by GTP, NADH, leucine, Mg2+ and other metabolites. An important route of glutaminolysis, glutamate dehydrogenase has been shown by early studies to bind both ADP and GTP on different sites71. GTP inhibits the activity of the enzyme72 while ADP exerts an activating effect; an increased ADP/GTP ratio thus signals a low-energy status in mitochondria that demands the replenishment of tricarboxylic acid (TCA) cycle intermediates via the activity of glutamate dehydrogenase. Additionally, leucine potently activates the enzyme73 via binding at the subunit interface of the hexameric enzyme complex74; the physiological importance of this regulation is underlined by the finding that leucine and its analogs stimulate insulin secretion through allosteric activation of glutamate dehydrogenase75. Perhaps most strikingly, pathogenic mutations have been identified in human glutamate dehydrogenase enzyme that specifically abolishes the allosteric inhibition by GTP76. These mutations lead to a gain-of-function effect on the GDH enzyme and hyperactive insulin secretion in beta cells77. Additionally, they increase hepatic ammonia production while restricting urea cycle capacity by reducing available glutamate for the synthesis of N-acetylglutamate, an allosteric activator of the urea cycle rate-limiting enzyme CPS1. The combination of these effects leads to infant and childhood hyperinsulinism and hyperammonemia syndrome, with the elevation of plasma ammonium levels and recurrent episodes of hypoglycemia, highlighting the essentiality of allosteric regulation of GDH for maintaining organismal metabolic homeostasis.

B. Sensing metabolites via protein post-translational modifications

Post-translational modifications of mitochondrial proteins may occur enzymatically or non-enzymatically. These modifications create molecular platforms for sensing the availability of diverse metabolites78. Of note, the distinctive chemical environment in the mitochondrial matrix is essential for shaping the target spectrum of such modifications. For example, high pH in the mitochondrial matrix favors the deprotonation of cysteine and lysine residues, which are critical for their reactivity. Indeed, non-enzymatic modifications of both cysteine and lysine are involved in sensing metabolic cues ranging from ROS to TCA cycle intermediates79,80.

The widespread distribution of reactive lysine residues renders a significant portion of mitochondrial proteome susceptible to acetylation by acetyl-CoA81, mostly via non-enzymatic reactions82. These modifications modulate the activities of diverse enzymes involved in the TCA cycle, electron transport chain, fatty acid and carbohydrate metabolism while providing interfaces for metabolic regulations. For example, acetylation of long-chain acyl-coenzyme A dehydrogenase (LCAD) on K42 reduces its enzymatic activity by approximately 40%83, thus potentially functioning as a coupling mechanism between cellular energetic state and fatty acid catabolism. In mitochondria, the non-enzymatic acetylation is reversed by NAD+-dependent, enzymatic deacetylation catalyzed by SIRT3, a member of the Sirtuin deacylation enzymes. Modulation of metabolic flux controlled by SIRT3 activity might be particularly important in adaptation to stress conditions such as starvation and hypoxia84,85. Similar to SIRT3, SIRT4 and SIRT5 also reside in mitochondria where they catalyze the removal of negatively charged lysine acyl modifications86,87. Together these post-translational modification mechanisms allow responses to different environmental perturbations and coordinate cellular metabolism via diverse downstream targets88,89.

Another intriguing example is the S-glutathionylation of protein cysteine residues, which have been shown to modulate the activity of diverse targets ranging from respiratory complexes to uncoupling proteins90,91. In mitochondria, a dedicated enzyme, glutaredoxin 2, catalyzes the reversible glutathionylation of thiol proteins. The thiol groups on both protein cysteine residues and glutathione could form disulfide bonds, and glutaredoxins catalyze protein S-glutathionylation by facilitating the disulfide bond exchange from oxidized glutathione (GSSG) to the protein-glutathione mixed disulfide bond. Remarkably, for proteins with two adjacent thiol groups capable of forming intra-molecular disulfide bonds, thermodynamic equilibrium between reduced and oxidized protein is predicted to be sensitive to glutathione levels92. Thus, in the case of S-glutathionylation, reversible modification by a single enzyme at equilibrium is sufficient to translate the availability of a given metabolite into altered protein behavior.

C. Sensing metabolites via the availability of cofactors, co-substrates and coenzymes

The mitochondria harbor multiple pathways for the synthesis, trafficking and functioning of coenzymes and cofactors, ranging from lipoic acid, iron-sulfur clusters to Coenzyme Q and heme. These processes offer effective leverages for metabolic control as their synthesis is often sensitive to the availability of metabolites. In many cases, reactions for the synthesis of these cofactors reside exclusively in mitochondria and would therefore be uniquely sensitive to fluctuations in mitochondrial metabolite levels.

The mitochondria are the primary location for the synthesis of iron-sulfur clusters93, which are essential cofactors involved in redox catalysis and the structural integrity of numerous protein complexes. Unsurprisingly, mitochondria also harbor perhaps the largest pool of intracellular iron, accounting for up to more than 50% of total cellular iron content94. While iron is indispensable for cellular metabolism, unbuffered free iron participates in Fenton reactions that produce reactive hydroxyl radicals. These toxic byproducts damage proteins, DNA and lipid bilayers and trigger cell death through ferroptosis. Thus, iron levels must be sensed and kept within a narrow range. In mammalian cells, two iron sensor proteins, iron regulatory protein 1 (IRP1) and regulatory protein 2 (IRP2), respond to iron levels and regulate the translation of proteins involved in iron metabolism via binding to the untranslated regions of their mRNAs95. The synthesis of iron-sulfur cluster cofactor plays a central role in both IRP1 and IRP2: for IRP1, an iron-sulfur cluster blocks its association with cognate mRNAs; iron deficiency prevents the incorporation of this iron-sulfur cluster to the apoprotein and releases it for the binding to the iron-responsive elements (IREs) on mRNAs. For IRP2, iron regulates its degradation through the E3 ligase F-box and leucine rich repeat protein 5 (FBXL5); an iron-sulfur cluster at the FBXL5-IRP2 interface mediates their association and also confers this system sensitivity to oxygen96. The reliance of iron sensing machinery on mitochondrially produced iron-sulfur cluster prosthetic groups orients whole-cell iron metabolism towards the demand for iron in the mitochondria, underscoring the critical role of this subcellular compartment in iron sensing and utilization. Additionally, iron-sulfur clusters are involved in control of mitochondrial-localized heme synthesis: two enzymes in the heme synthesis pathway, aminolevulinic acid dehydratase (ALAD) and ferrochelatase (FECH), have been shown to harbor iron-sulfur clusters as an essential prosthetic group for their action97,98. Of note, the iron-sulfur cluster is absent in the homologs of FECH in lower eukaryotes, indicating that this mechanism might be selected for its ability to coordinate heme backbone synthesis with iron availability.

A similar principle applies to the regulation of ETC assembly by mitochondrial fatty acid biosynthesis. Mitochondria possess an independent pathway, the mitochondrial fatty acid synthesis (mtFAS) pathway, to produce short-chain fatty acid primarily for the synthesis of lipoic acid, an essential cofactor for numerous mitochondrial enzymes50. This pathway produces long acyl chains attached to the acyl carrier proteins (ACP). The acylated ACP interacts with key ETC assembly factors and is predicted to be essential for their biogenesis99. As the mitochondrial fatty acid synthesis is believed to be sensitive to the limitation of acetyl CoA, this mechanism enables the cells to detect acetyl CoA levels using cofactor production (lipoic acid and acyl-ACP) as a proxy, and control downstream metabolism via ETC assembly and lipoic acid-containing enzyme activities.

An intriguing mechanism by which TCA cycle intermediates are sensed involves alpha-ketoglutarate-dependent dioxygenases, a versatile group of iron-containing enzymes that includes key players in epigenetic regulation100, oxygen sensing, lipid metabolism, and other critical processes. These enzymes couple the decarboxylation of alpha-ketoglutarate with the oxidation of the substrate101, and in many case the predicted KM of those enzymes to alpha-ketoglutarate (αKG) overlaps with its physiological levels102, suggesting that their activity may dynamically respond to intracellular αKG levels. Indeed, it has been shown that these enzymes sense changes in cellular αKG103 and mediate the effect of altered mitochondrial metabolism on epigenetic landscape and cell fate104. Importantly, alpha-ketoglutarate-dependent dioxygenases are also competitively inhibited by TCA cycle-derived metabolites fumarate, succinate and oncometabolite 2-hydroxyglutarate produced by mutant isocitrate dehydrogenases (IDH1/2); these mitochondrial metabolites accumulate under environmental stress (such as hypoxia105 and inflammation106) or oncogenic mutations107 and trigger profound changes in metabolic and epigenetic profile of the cell.

D. Sensing metabolites via the physical state of the mitochondrial membrane

A unique feature enabled by a compartmentalized organelle is the rich variation in membrane physical and chemical properties that serves as the basis for sensing diverse metabolic cues. Fluctuations in mitochondrial membrane lipid composition leads to changing thickness, curvature and asymmetry of membranes and alter their interaction with membrane proteins, leading to conformational changes that could be captured by downstream signaling pathways.

Carnitine Palmitoyltransferase 1A (CPT1A) is a mitochondrial outer membrane-anchored protein that serves as an important checkpoint for the entrance of fatty acid into beta-oxidation. Apart from being allosterically regulated by malonyl-CoA, CPT1A also harbors an N-terminal domain that adopts different conformation in response to changes in membrane curvature108,109. This conformational change modifies the sensitivity of CPT1A to the regulation of malonyl-CoA, creating an additional layer of regulation that may reflect the long-term changes in the metabolic state. The chemical composition of the lipid bilayer could also directly impact its physical property and engage relevant sensors. Cardiolipin is a phospholipid species enriched specifically in the mitochondria and essential for its function110,111. The last step of cardiolipin production is catalyzed by Tafazzin, an unspecific phospholipid-lysophospholipid transacylase that leads to the enrichment of linoleoyl hydrocarbon chains in cardiolipin. Sensing of substrate saturation, however, is achieved through the preferential catalysis of Tafazzin in the negatively curved membranes, which are enriched in unsaturated phospholipid and cardiolipin112,113. Inferring metabolic state via membrane physical state appears to be a recurring theme coopted for metabolic signaling in organelles.

Outlook

Decades of research have unveiled the pivotal role of metabolic sensing and regulation in the mitochondria. These findings have far-reaching implications for our understanding of cellular metabolism and human disease, as numerous inborn errors of metabolism have been attributed to defects of metabolic sensing and control mechanisms involving mitochondria. Clinical manifestations of these diseases underscore the significance of intact metabolic control mechanisms that ensure efficient metabolic output while adapting swiftly to environmental perturbation.

In recent years, renewed interest in metabolic compartmentalization has led to the deorphanization of numerous components in organellar metabolite transport and regulation41,42,114116, aided by an array of novel technologies. Among them include improved workflows for the isolation of organelles117120, many of which shorten the time interval between cell lysis and extraction, allowing better preservation of metabolome and proteome for downstream analysis. Some workflows involve labeling the organelle of interest with genetically-encoded tags, which enables cell type-specific isolation of organelles when applied to animal models. In parallel, an expanding toolkit based on proximal labeling enables the compartment-specific isolation of proteins without isolation of organelles themselves121. Modification of this strategy also enables profiling of proteins with high temporal resolution122, integration with cysteine chemical proteomics123 and characterization of compartments that cannot be isolated with conventional methods124.

Metabolite-protein interaction is central to sensing of metabolic signals and remains challenging to reliably study. New platforms such as Mass spectrometry Integrated with equilibrium Dialysis for the discovery of Allostery Systematically (MIDAS) utilize purified proteins to achieve the enrichment of protein-binding metabolites and enables metabolome-wide profiling given any single protein of interest125. Conversely, for a given metabolite, association with its protein binding partners induces altered protein stability, solubility and protease accessibility, which would be profiled at whole proteome-scale by quantitative mass-spectrometry126128. These new methods provide unprecedented opportunity for the systemic discovery of potential metabolic sensors and signaling components.

These advances reveal exciting new directions of research toward understanding the mechanistic logic of metabolic regulation in organelles. The mitochondria harbor distinct biochemical environments that do not automatically equilibrate with the cytosol, yet compared with our understanding of nutrient sensing and signaling in the cytosol 6, parallel mechanisms in the mitochondria are still understudied. Below, we listed some questions that need to be addressed in this area:

  • Which mitochondrial metabolites require homeostatic regulation to maintain a relatively stable concentration distinct from the cytosol? What are the sensing and control mechanisms underlying such regulation?

  • Metabolite transporters on the mitochondrial inner membrane could function as control sites for mitochondrial metabolites. Indeed, for substrates such as glutathione and iron, evidence suggests that they participate in post-translational regulation of their transporters41,129. What is the mechanism coupling metabolite sensing to mitochondrial import?

  • Mechanisms for retrograde signaling from the mitochondria to the cytosol have been described from yeast to humans that trigger a multitude of effects through nuclear gene expression. However, much less is known about how mitochondrial transcription and translation respond to the metabolic status of the cytosol. How are metabolic signals and stresses relayed to the mitochondria from the cytosol or other organelles?

Addressing these questions would require the concerted effort from researchers at the intersection of enzymology, mitochondrial biology, cell signaling and physiology to push the frontier of our understanding of this awe-inspiring symbiosis between mitochondria and host eukaryotic cells.

Figure 1. Mitochondria adopt feedback and feedforward control circuits to achieve metabolic homeostasis or adaptation.

Figure 1.

(A) Schematic of a mitochondrial feedback circuit that ensures metabolic conservation by limiting the synthesis of metabolites demanded in mitochondria. PANK2, a mitochondrial enzyme in the Coenzyme A synthesis pathway, is allosterically inhibited by CoA and acetyl-CoA. (B) Schematic of a mitochondrial feedback circuit dedicated to maintaining the mitochondrial levels of a metabolite. Glutathione has been observed to downregulate its mitochondrial importer SLC25A39, functioning in a feedback mechanism likely to achieve homeostatic regulation of mitochondrial glutathione levels. (C) Schematic of a mitochondrial feedback circuit that restrains the production of toxic mitochondrial metabolite. Heme inhibits the import of the rate-limiting enzyme in its de novo synthesis, ALAS1/ALAS2, to avoid the accumulation of toxic porphyrin intermediates. (D) Schematic of a mitochondrial feedforward circuit that enables metabolic plasticity. Urea cycle intermediate arginine stimulates the synthesis of N-acetylglutamate, an allosteric activator of urea cycle enzyme CPS1, allowing robust activation of the urea cycle upon the influx of ammonium nitrogen. (E) Schematic of a mitochondrial feedforward circuit that prevents futile cycles. Fatty acid synthesis substrate malonyl-CoA inhibits the entrance of fatty acid into the reverse reaction, β-oxidation, by allosterically inhibiting CPS1. (F) Schematic of mitochondrial feedforward circuits that trigger adaptive responses to stress. The release of mitochondrial DNA or cytochrome C triggers stress response signaling via the cGAS-STING pathway or the integrated stress response (ISR).

Figure 2. Molecular basis of metabolite sensing in mitochondria.

Figure 2.

Schematics for different mechanisms by which metabolites alter the properties of a sensor protein. (A) Metabolites could directly interact with metabolite sensors and modify their behavior through allosteric regulation or post-translational modification. For example, GTP allosterically inhibits glutamate dehydrogenase, which connects the mitochondrial energy state with the replenishment of TCA cycle intermediates. (B) Metabolites could affect enzymatic activity by serving as substrates of protein post-translational modifications. The long-chain acyl-CoA dehydrogenase responds to mitochondrial acetyl-CoA levels via acetylation of residue K42, a reversible modification that reduces its enzymatic activity. (C) Metabolites could modulate the activity of sensor proteins by affecting the incorporation of cofactors and prosthetic groups into apoproteins. Human aminolevulinic acid dehydratase requires an iron-sulfur [4Fe-4S] cluster for its activity, coordinate heme intermediate synthesis with iron availability. (D) The physical properties of mitochondrial membranes are sensitive to their chemical composition, providing a platform for membrane-bound sensor proteins to respond to metabolic stimuli. The cardiolipin-remodeling enzyme Tafazzin preferentially incorporates unsaturated acyl chains into cardiolipin through activation by negative membrane curvature.

Acknowledgment

K.B. is supported by the Mark Foundation Emerging Leader Award, the Pew Charitable Trust and is a Searle Scholar (KB) and a Pew-Stewart Scholar (KB).

Footnotes

Declaration of interests

K.B. is a scientific advisor to Nanocare Pharmaceuticals and Atavistik Bio. Y.L. declares no competing interests.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Sagan L. (1967). On the origin of mitosing cells. Journal of Theoretical Biology 14, 225-IN6. 10.1016/0022-5193(67)90079-3. [DOI] [PubMed] [Google Scholar]
  • 2.Roger AJ, Muñoz-Gómez SA, and Kamikawa R. (2017). The Origin and Diversification of Mitochondria. Current Biology 27, R1177–R1192. 10.1016/j.cub.2017.09.015. [DOI] [PubMed] [Google Scholar]
  • 3.Bar-Peled L, and Kory N. (2022). Principles and functions of metabolic compartmentalization. Nat Metab 4, 1232–1244. 10.1038/s42255-022-00645-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bock FJ, and Tait SWG (2020). Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21, 85–100. 10.1038/s41580-019-0173-8. [DOI] [PubMed] [Google Scholar]
  • 5.Pickrell AM, and Youle RJ (2015). The Roles of PINK1, Parkin and Mitochondrial Fidelity in Parkinson’s Disease. Neuron 85, 257–273. 10.1016/j.neuron.2014.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Efeyan A, Comb WC, and Sabatini DM (2015). Nutrient-sensing mechanisms and pathways. Nature 517, 302–310. 10.1038/nature14190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chantranupong L, Wolfson RL, and Sabatini DM (2015). Nutrient Sensing Mechanisms Across Evolution. Cell 161, 67–83. 10.1016/j.cell.2015.02.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Arcondéguy T, Jack R, and Merrick M. (2001). PII Signal Transduction Proteins, Pivotal Players in Microbial Nitrogen Control. Microbiol Mol Biol Rev 65, 80–105. 10.1128/MMBR.65.1.80-105.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liu Y, Makarova KS, Huang W-C, Wolf YI, Nikolskaya AN, Zhang X, Cai M, Zhang C-J, Xu W, Luo Z, et al. (2021). Expanded diversity of Asgard archaea and their relationships with eukaryotes. Nature 593, 553–557. 10.1038/s41586-021-03494-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ward DM, and Cloonan SM (2019). Mitochondrial Iron in Human Health and Disease. Annu Rev Physiol 81, 453–482. 10.1146/annurev-physiol-020518-114742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ortiz-Prado E, Dunn JF, Vasconez J, Castillo D, and Viscor G. (2019). Partial pressure of oxygen in the human body: a general review. Am J Blood Res 9, 1–14. [PMC free article] [PubMed] [Google Scholar]
  • 12.Ye J, and Medzhitov R. (2019). Control strategies in systemic metabolism. Nat Metab 1, 947–957. 10.1038/s42255-019-0118-8. [DOI] [PubMed] [Google Scholar]
  • 13.Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, et al. (2002). Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. The EMBO Journal 21, 5216–5224. 10.1093/emboj/cdf516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Warnatz H-J, Schmidt D, Manke T, Piccini I, Sultan M, Borodina T, Balzereit D, Wruck W, Soldatov A, Vingron M, et al. (2011). The BTB and CNC Homology 1 (BACH1) Target Genes Are Involved in the Oxidative Stress Response and in Control of the Cell Cycle *. Journal of Biological Chemistry 286, 23521–23532. 10.1074/jbc.M111.220178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hofmeyr J-HS, and Cornish-Bowden A. (2000). Regulating the cellular economy of supply and demand. FEBS Letters 476, 47–51. 10.1016/S0014-5793(00)01668-9. [DOI] [PubMed] [Google Scholar]
  • 16.Strelko CL, Lu W, Dufort FJ, Seyfried TN, Chiles TC, Rabinowitz JD, and Roberts MF (2011). Itaconic Acid Is a Mammalian Metabolite Induced during Macrophage Activation. J. Am. Chem. Soc 133, 16386–16389. 10.1021/ja2070889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sugimoto M, Sakagami H, Yokote Y, Onuma H, Kaneko M, Mori M, Sakaguchi Y, Soga T, and Tomita M. (2012). Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics 8, 624–633. 10.1007/s11306-011-0353-9. [DOI] [Google Scholar]
  • 18.Shin J-H, Yang J-Y, Jeon B-Y, Yoon YJ, Cho S-N, Kang Y-H, Ryu DH, and Hwang G-S (2011). 1H NMR-based Metabolomic Profiling in Mice Infected with Mycobacterium tuberculosis. J. Proteome Res 10, 2238–2247. 10.1021/pr101054m. [DOI] [PubMed] [Google Scholar]
  • 19.Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, Binz T, Wegner A, Tallam A, Rausell A, et al. (2013). Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proceedings of the National Academy of Sciences 110, 7820–7825. 10.1073/pnas.1218599110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, et al. (2018). Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–117. 10.1038/nature25986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Heinz A, Nonnenmacher Y, Henne A, Khalil M-A, Bejkollari K, Dostert C, Hosseini S, Goldmann O, He W, Palorini R, et al. (2022). Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868, 166530. 10.1016/j.bbadis.2022.166530. [DOI] [PubMed] [Google Scholar]
  • 22.Chiabrando D, Vinchi F, Fiorito V, Mercurio S, and Tolosano E. (2014). Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Frontiers in Pharmacology 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yamamoto M, Hayashi N, and Kikuchi G. (1983). Translational inhibition by heme of the synthesis of hepatic δ-aminolevulinate synthase in a cell-free system. Biochemical and Biophysical Research Communications 115, 225–231. 10.1016/0006-291X(83)90993-2. [DOI] [PubMed] [Google Scholar]
  • 24.Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF, Alcedo JA, and Wetterhahn KE (1991). Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Archives of Biochemistry and Biophysics 289, 387–392. 10.1016/0003-9861(91)90428-L. [DOI] [PubMed] [Google Scholar]
  • 25.Kubota Y, Nomura K, Katoh Y, Yamashita R, Kaneko K, and Furuyama K. (2016). Novel Mechanisms for Heme-dependent Degradation of ALAS1 Protein as a Component of Negative Feedback Regulation of Heme Biosynthesis *. Journal of Biological Chemistry 291, 20516–20529. 10.1074/jbc.M116.719161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lathrop JT, and Timko MP (1993). Regulation by Heme of Mitochondrial Protein Transport Through a Conserved Amino Acid Motif. Science 259, 522–525. 10.1126/science.8424176. [DOI] [PubMed] [Google Scholar]
  • 27.Balwani M, and Desnick RJ (2012). The porphyrias: advances in diagnosis and treatment. Blood 120, 4496–4504. 10.1182/blood-2012-05-423186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Dowman JK, Gunson BK, Bramhall S, Newsome PN, and Badminton MN (2011). Liver Transplantation From Donors With Acute Intermittent Porphyria. Ann Intern Med 154, 571–572. 10.7326/0003-4819-154-8-201104190-00015. [DOI] [PubMed] [Google Scholar]
  • 29.Johnson MA, Kuo YM, Westaway SK, Parker SM, Ching KHL, Gitschier J, and Hayflick SJ (2004). Mitochondrial Localization of Human PANK2 and Hypotheses of Secondary Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration. Annals of the New York Academy of Sciences 1012, 282–298. 10.1196/annals.1306.023. [DOI] [PubMed] [Google Scholar]
  • 30.Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, and Hayflick SJ (2001). A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28, 345–349. 10.1038/ng572. [DOI] [PubMed] [Google Scholar]
  • 31.Idell-Wenger JA, Grotyohann LW, and Neely JR (1978). Coenzyme A and carnitine distribution in normal and ischemic hearts. Journal of Biological Chemistry 253, 4310–4318. 10.1016/S0021-9258(17)34721-X. [DOI] [PubMed] [Google Scholar]
  • 32.Orsatti L, Orsale MV, Pasquale P. di Vecchi A, Colaceci F, Ciammaichella A, Rossetti I, Bonelli F, Baumgaertel K, Liu K, et al. (2021). Turnover rate of coenzyme A in mouse brain and liver. PLOS ONE 16, e0251981. 10.1371/journal.pone.0251981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rechsteiner M, Hillyard D, and Olivera BM (1976). Turnover of nicotinamide adenine dinucleotide in cultures of human cells. Journal of Cellular Physiology 88, 207–217. 10.1002/jcp.1040880210. [DOI] [PubMed] [Google Scholar]
  • 34.Vallari DS, Jackowski S, and Rock CO (1987). Regulation of pantothenate kinase by coenzyme A and its thioesters. Journal of Biological Chemistry 262, 2468–2471. 10.1016/S0021-9258(18)61527-3. [DOI] [PubMed] [Google Scholar]
  • 35.Rock CO, Calder RB, Karim MA, and Jackowski S. (2000). Pantothenate Kinase Regulation of the Intracellular Concentration of Coenzyme A *. Journal of Biological Chemistry 275, 1377–1383. 10.1074/jbc.275.2.1377. [DOI] [PubMed] [Google Scholar]
  • 36.Hu M, Li P, Wang C, Feng X, Geng Q, Chen W, Marthi M, Zhang W, Gao C, Reid W, et al. (2022). Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. Cell 185, 2292–2308.e20. 10.1016/j.cell.2022.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sevier CS, Qu H, Heldman N, Gross E, Fass D, and Kaiser CA (2007). Modulation of Cellular Disulfide-Bond Formation and the ER Redox Environment by Feedback Regulation of Ero1. Cell 129, 333–344. 10.1016/j.cell.2007.02.039. [DOI] [PubMed] [Google Scholar]
  • 38.Baile MG, Lu YW, and Claypool SM (2014). The topology and regulation of cardiolipin biosynthesis and remodeling in yeast. Chem Phys Lipids 179, 25–31. 10.1016/j.chemphyslip.2013.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Connerth M, Tatsuta T, Haag M, Klecker T, Westermann B, and Langer T. (2012). Intramitochondrial Transport of Phosphatidic Acid in Yeast by a Lipid Transfer Protein. Science 338, 815–818. 10.1126/science.1225625. [DOI] [PubMed] [Google Scholar]
  • 40.Griffith OW, and Meister A. (1985). Origin and turnover of mitochondrial glutathione. Proceedings of the National Academy of Sciences 82, 4668–4672. 10.1073/pnas.82.14.4668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wang Y, Yen FS, Zhu XG, Timson RC, Weber R, Xing C, Liu Y, Allwein B, Luo H, Yeh H-W, et al. (2021). SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells. Nature 599, 136–140. 10.1038/s41586-021-04025-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Shi X, Reinstadler B, Shah H, To T-L, Byrne K, Summer L, Calvo SE, Goldberger O, Doench JG, Mootha VK, et al. (2022). Combinatorial GxGxE CRISPR screen identifies SLC25A39 in mitochondrial glutathione transport linking iron homeostasis to OXPHOS. Nat Commun 13, 2483. 10.1038/s41467-022-30126-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ruprecht JJ, and Kunji ERS (2020). The SLC25 Mitochondrial Carrier Family: Structure and Mechanism. Trends in Biochemical Sciences 45, 244–258. 10.1016/j.tibs.2019.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Folin O. (1905). Laws governing the chemical composition of urine. Am. J. Physiol 13, 66–115. 10.1152/ajplegacy.1905.13.1.66. [DOI] [Google Scholar]
  • 45.Watford M. (2003). The urea cycle: Teaching intermediary metabolism in a physiological setting. Biochemistry and Molecular Biology Education 31, 289–297. 10.1002/bmb.2003.494031050249. [DOI] [Google Scholar]
  • 46.Hall LM, Metzenberg RL, and Cohen PP (1958). ISOLATION AND CHARACTERIZATION OF A NATURALLY OCCURRING COFACTOR OF CARBAMYL PHOSPHATE BIOSYNTHESIS. Journal of Biological Chemistry 230, 1013–1021. 10.1016/S0021-9258(18)70523-1. [DOI] [PubMed] [Google Scholar]
  • 47.Shigesada K, and Tatibana M. (1971). Enzymatic synthesis of acetylglutamate by mammalian liver preparations and its stimulation by arginine. Biochemical and Biophysical Research Communications 44, 1117–1124. 10.1016/S0006-291X(71)80201-2. [DOI] [PubMed] [Google Scholar]
  • 48.CALDOVIC L, MORIZONO H, YU X, THOMPSON M, SHI D, GALLEGOS R, ALLEWELL NM, MALAMY MH, and TUCHMAN M. (2002). Identification, cloning and expression of the mouse N-acetylglutamate synthase gene. Biochemical Journal 364, 825–831. 10.1042/bj20020161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sonaimuthu P, Senkevitch E, Haskins N, Uapinyoying P, McNutt M, Morizono H, Tuchman M, and Caldovic L. (2018). Impaired ureagenesis due to arginine-insensitive N-acetylglutamate synthase. 425959. 10.1101/425959. [DOI] [PMC free article] [PubMed]
  • 50.Reglero A, Rivas J, Mendelson J, Wallace R, and Grisolia S. (1977). Deacylation and transacetylation of acetyl glutamate and acetyl ornithine in rat liver. FEBS Letters 81, 13–17. 10.1016/0014-5793(77)80917-4. [DOI] [PubMed] [Google Scholar]
  • 51.Staddon JM, Bradford NM, and McGivan JD (1984). Effects of glucagon in vivo on the N-acetylglutamate, glutamate and glutamine contents of rat liver. Biochem J 217, 855–857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hensgens HESJ, Verhoeven AJ, and Meijer AJ (1980). The Relationship between Intramitochondrial N-Acetylglutamate and Activity of Carbamoyl-Phosphate Synthetase (Ammonia). European Journal of Biochemistry 107, 197–205. 10.1111/j.1432-1033.1980.tb04640.x. [DOI] [PubMed] [Google Scholar]
  • 53.Leonardi R, Rock CO, Jackowski S, and Zhang Y-M (2007). Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine. Proc Natl Acad Sci U S A 104, 1494–1499. 10.1073/pnas.0607621104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Newsholme EA, Challiss RAJ, and Crabtree B. (1984). Substrate cycles: their role in improving sensitivity in metabolic control. Trends in Biochemical Sciences 9, 277–280. 10.1016/0968-0004(84)90165-8. [DOI] [Google Scholar]
  • 55.Sazanov L. a., and Jackson J. b. (1994). Proton-translocating transhydrogenase and NAD- and NADP-linked isocitrate dehydrogenases operate in a substrate cycle which contributes to fine regulation of the tricarboxylic acid cycle activity in mitochondria. FEBS Letters 344, 109–116. 10.1016/0014-5793(94)00370-X. [DOI] [PubMed] [Google Scholar]
  • 56.Foster DW (2012). Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Invest 122, 1958–1959. 10.1172/JCI63967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.McGarry JD, Meier JM, and Foster DW (1973). The Effects of Starvation and Refeeding on Carbohydrate and Lipid Metabolism in Vivo and in the Perfused Rat Liver: THE RELATIONSHIP BETWEEN FATTY ACID OXIDATION AND ESTERIFICATION IN THE REGULATION OF KETOGENESIS REGULATION OF KETOGENESIS. Journal of Biological Chemistry 248, 270–278. 10.1016/S0021-9258(19)44471-2. [DOI] [PubMed] [Google Scholar]
  • 58.McGarry JD, Mannaerts GP, and Foster DW (1977). A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 60, 265–270. 10.1172/JCI108764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.McGarry JD, Leatherman GF, and Foster DW (1978). Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. Journal of Biological Chemistry 253, 4128–4136. 10.1016/S0021-9258(17)34693-8. [DOI] [PubMed] [Google Scholar]
  • 60.Winder WW, and Hardie DG (1996). Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. American Journal of Physiology-Endocrinology and Metabolism 270, E299–E304. 10.1152/ajpendo.1996.270.2.E299. [DOI] [PubMed] [Google Scholar]
  • 61.Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, and Winder WW (2002). Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. Journal of Applied Physiology 92, 2475–2482. 10.1152/japplphysiol.00071.2002. [DOI] [PubMed] [Google Scholar]
  • 62.Condon KJ, Orozco JM, Adelmann CH, Spinelli JB, van der Helm PW, Roberts JM, Kunchok T, and Sabatini DM (2021). Genome-wide CRISPR screens reveal multitiered mechanisms through which mTORC1 senses mitochondrial dysfunction. Proceedings of the National Academy of Sciences 118, e2022120118. 10.1073/pnas.2022120118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Fessler E, Eckl E-M, Schmitt S, Mancilla IA, Meyer-Bender MF, Hanf M, Philippou-Massier J, Krebs S, Zischka H, and Jae LT (2020). A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature 579, 433–437. 10.1038/s41586-020-2076-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Guo X, Aviles G, Liu Y, Tian R, Unger BA, Lin Y-HT, Wiita AP, Xu K, Correia MA, and Kampmann M. (2020). Mitochondrial stress is relayed to the cytosol by an OMA1–DELE1–HRI pathway. Nature 579, 427–432. 10.1038/s41586-020-2078-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Fessler E, Krumwiede L, and Jae LT (2022). DELE1 tracks perturbed protein import and processing in human mitochondria. Nat Commun 13, 1853. 10.1038/s41467-022-29479-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Kalkavan H, Chen MJ, Crawford JC, Quarato G, Fitzgerald P, Tait SWG, Goding CR, and Green DR (2022). Sublethal cytochrome c release generates drug-tolerant persister cells. Cell 185, 3356–3374.e22. 10.1016/j.cell.2022.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Melber A, and Haynes CM (2018). UPRmt regulation and output: a stress response mediated by mitochondrial-nuclear communication. Cell Res 28, 281–295. 10.1038/cr.2018.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Chen Q, Sun L, and Chen ZJ (2016). Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing. Nat Immunol 17, 1142–1149. 10.1038/ni.3558. [DOI] [PubMed] [Google Scholar]
  • 69.Breaker RR (2012). Riboswitches and the RNA World. Cold Spring Harb Perspect Biol 4, a003566. 10.1101/cshperspect.a003566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Karwi QG, Jörg AR, and Lopaschuk GD (2019). Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism. Biochemical Journal 476, 1695–1712. 10.1042/BCJ20180617. [DOI] [PubMed] [Google Scholar]
  • 71.Koberstein R, and Sund H. (1973). Studies of Glutamate Dehydrogenase. European Journal of Biochemistry 36, 545–552. 10.1111/j.1432-1033.1973.tb02942.x. [DOI] [PubMed] [Google Scholar]
  • 72.Frieden C. (1963). Glutamate Dehydrogenase: V. THE RELATION OF ENZYME STRUCTURE TO THE CATALYTIC FUNCTION. Journal of Biological Chemistry 238, 3286–3299. 10.1016/S0021-9258(18)48660-7. [DOI] [PubMed] [Google Scholar]
  • 73.Fahien LA, Teller JK, Macdonald MJ, and Fahien CM (1990). Regulation of glutamate dehydrogenase by Mg2+ and magnification of leucine activation by Mg2+. Mol Pharmacol 37, 943–949. [PubMed] [Google Scholar]
  • 74.Tomita T, Kuzuyama T, and Nishiyama M. (2011). Structural Basis for Leucine-induced Allosteric Activation of Glutamate Dehydrogenase. J Biol Chem 286, 37406–37413. 10.1074/jbc.M111.260265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Sener A, and Malaisse WJ (1980). L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288, 187–189. 10.1038/288187a0. [DOI] [PubMed] [Google Scholar]
  • 76.Stanley CA, Lieu YK, Hsu BYL, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, and Poncz M. (1998). Hyperinsulinism and Hyperammonemia in Infants with Regulatory Mutations of the Glutamate Dehydrogenase Gene. N Engl J Med 338, 1352–1357. 10.1056/NEJM199805073381904. [DOI] [PubMed] [Google Scholar]
  • 77.Fahien LA, and MacDonald MJ (2011). The Complex Mechanism of Glutamate Dehydrogenase in Insulin Secretion. Diabetes 60, 2450–2454. 10.2337/db10-1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Sawant Dessai A, Kalhotra P, Novickis AT, and Dasgupta S. (2022). Regulation of tumor metabolism by post translational modifications on metabolic enzymes. Cancer Gene Ther, 1–11. 10.1038/s41417-022-00521-x. [DOI] [PMC free article] [PubMed]
  • 79.Park J, Chen Y, Tishkoff DX, Peng C, Tan M, Dai L, Xie Z, Zhang Y, Zwaans BMM, Skinner ME, et al. (2013). SIRT5-Mediated Lysine Desuccinylation Impacts Diverse Metabolic Pathways. Molecular Cell 50, 919–930. 10.1016/j.molcel.2013.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Chouchani ET, Kazak L, Jedrychowski MP, Lu GZ, Erickson BK, Szpyt J, Pierce KA, Laznik-Bogoslavski D, Vetrivelan R, Clish CB, et al. (2016). Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1. Nature 532, 112–116. 10.1038/nature17399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, et al. (2006). Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey. Molecular Cell 23, 607–618. 10.1016/j.molcel.2006.06.026. [DOI] [PubMed] [Google Scholar]
  • 82.Wagner GR, and Payne RM (2013). Widespread and Enzyme-independent Nϵ-Acetylation and Nϵ-Succinylation of Proteins in the Chemical Conditions of the Mitochondrial Matrix*, ♦. Journal of Biological Chemistry 288, 29036–29045. 10.1074/jbc.M113.486753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121–125. 10.1038/nature08778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Ahn B-H, Kim H-S, Song S, Lee IH, Liu J, Vassilopoulos A, Deng C-X, and Finkel T. (2008). A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proceedings of the National Academy of Sciences 105, 14447–14452. 10.1073/pnas.0803790105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Porter GA, Urciuoli WR, Brookes PS, and Nadtochiy SM (2014). SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts. American Journal of Physiology-Heart and Circulatory Physiology 306, H1602–H1609. 10.1152/ajpheart.00027.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, et al. (2011). Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase. Science 334, 806–809. 10.1126/science.1207861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Anderson KA, Huynh FK, Fisher-Wellman K, Stuart JD, Peterson BS, Douros JD, Wagner GR, Thompson JW, Madsen AS, Green MF, et al. (2017). SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. Cell Metabolism 25, 838–855.e15. 10.1016/j.cmet.2017.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y, et al. (2010). Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux. Science 327, 1004–1007. 10.1126/science.1179687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, et al. (2010). Regulation of Cellular Metabolism by Protein Lysine Acetylation. Science 327, 1000–1004. 10.1126/science.1179689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Mailloux RJ, Seifert EL, Bouillaud F, Aguer C, Collins S, and Harper M-E (2011). Glutathionylation Acts as a Control Switch for Uncoupling Proteins UCP2 and UCP3. J Biol Chem 286, 21865–21875. 10.1074/jbc.M111.240242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Taylor ER, Hurrell F, Shannon RJ, Lin T-K, Hirst J, and Murphy MP (2003). Reversible Glutathionylation of Complex I Increases Mitochondrial Superoxide Formation *. Journal of Biological Chemistry 278, 19603–19610. 10.1074/jbc.M209359200. [DOI] [PubMed] [Google Scholar]
  • 92.Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, and Murphy MP (2004). Glutaredoxin 2 Catalyzes the Reversible Oxidation and Glutathionylation of Mitochondrial Membrane Thiol Proteins: IMPLICATIONS FOR MITOCHONDRIAL REDOX REGULATION AND ANTIOXIDANT DEFENSE*. Journal of Biological Chemistry 279, 47939–47951. 10.1074/jbc.M408011200. [DOI] [PubMed] [Google Scholar]
  • 93.Braymer JJ, and Lill R. (2017). Iron–sulfur cluster biogenesis and trafficking in mitochondria. Journal of Biological Chemistry 292, 12754–12763. 10.1074/jbc.R117.787101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Jhurry ND, Chakrabarti M, McCormick SP, Holmes-Hampton GP, and Lindahl PA (2012). Biophysical Investigation of the Ironome of Human Jurkat Cells and Mitochondria. Biochemistry 51, 5276–5284. 10.1021/bi300382d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Zhang D-L, Ghosh MC, and Rouault TA (2014). The physiological functions of iron regulatory proteins in iron homeostasis - an update. Frontiers in Pharmacology 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Wang H, Shi H, Rajan M, Canarie ER, Hong S, Simoneschi D, Pagano M, Bush MF, Stoll S, Leibold EA, et al. (2020). FBXL5 Regulates IRP2 Stability in Iron Homeostasis via an Oxygen-Responsive [2Fe2S] Cluster. Molecular Cell 78, 31–41.e5. 10.1016/j.molcel.2020.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Liu G, Sil D, Maio N, Tong W-H, Bollinger JM, Krebs C, and Rouault TA (2020). Heme biosynthesis depends on previously unrecognized acquisition of iron-sulfur cofactors in human amino-levulinic acid dehydratase. Nat Commun 11, 6310. 10.1038/s41467-020-20145-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Dailey HA, Finnegan MG, and Johnson MK (1994). Human ferrochelatase is an iron-sulfur protein. Biochemistry 33, 403–407. 10.1021/bi00168a003. [DOI] [PubMed] [Google Scholar]
  • 99.Van Vranken JG, Nowinski SM, Clowers KJ, Jeong M-Y, Ouyang Y, Berg JA, Gygi JP, Gygi SP, Winge DR, and Rutter J. (2018). ACP acylation is an acetyl-CoA-dependent modification required for electron transport chain assembly. Mol Cell 71, 567–580.e4. 10.1016/j.molcel.2018.06.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, and Zhang Y. (2006). Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811–816. 10.1038/nature04433. [DOI] [PubMed] [Google Scholar]
  • 101.Loenarz C, and Schofield CJ (2008). Expanding chemical biology of 2-oxoglutarate oxygenases. Nat Chem Biol 4, 152–156. 10.1038/nchembio0308-152. [DOI] [PubMed] [Google Scholar]
  • 102.Islam Md.S., Leissing TM, Chowdhury R, Hopkinson RJ, and Schofield CJ (2018). 2-Oxoglutarate-Dependent Oxygenases. Annual Review of Biochemistry 87, 585–620. 10.1146/annurev-biochem-061516-044724. [DOI] [PubMed] [Google Scholar]
  • 103.Carey BW, Finley LWS, Cross JR, Allis CD, and Thompson CB (2015). Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518, 413–416. 10.1038/nature13981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Morris JP, Yashinskie JJ, Koche R, Chandwani R, Tian S, Chen C-C, Baslan T, Marinkovic ZS, Sánchez-Rivera FJ, Leach SD, et al. (2019). α-Ketoglutarate links p53 to cell fate during tumour suppression. Nature 573, 595–599. 10.1038/s41586-019-1577-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, et al. (2014). Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435. 10.1038/nature13909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al. (2013). Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242. 10.1038/nature11986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. (2009). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–744. 10.1038/nature08617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Rao JN, Warren GZL, Estolt-Povedano S, Zammit VA, and Ulmer TS (2011). An Environment-dependent Structural Switch Underlies the Regulation of Carnitine Palmitoyltransferase 1A*♦. Journal of Biological Chemistry 286, 42545–42554. 10.1074/jbc.M111.306951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Frigini EN, Barrera EE, Pantano S, and Porasso RD (2020). Role of membrane curvature on the activation/deactivation of Carnitine Palmitoyltransferase 1A: A coarse grain molecular dynamic study. Biochimica et Biophysica Acta (BBA) - Biomembranes 1862, 183094. 10.1016/j.bbamem.2019.183094. [DOI] [PubMed] [Google Scholar]
  • 110.Arias-Cartin R, Grimaldi S, Arnoux P, Guigliarelli B, and Magalon A. (2012). Cardiolipin binding in bacterial respiratory complexes: Structural and functional implications. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1817, 1937–1949. 10.1016/j.bbabio.2012.04.005. [DOI] [PubMed] [Google Scholar]
  • 111.Malhotra K, Modak A, Nangia S, Daman TH, Gunsel U, Robinson VL, Mokranjac D, May ER, and Alder NN (2017). Cardiolipin mediates membrane and channel interactions of the mitochondrial TIM23 protein import complex receptor Tim50. Science Advances 3, e1700532. 10.1126/sciadv.1700532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Elías-Wolff F, Lindén M, Lyubartsev AP, and Brandt EG (2019). Curvature sensing by cardiolipin in simulated buckled membranes. Soft Matter 15, 792–802. 10.1039/C8SM02133C. [DOI] [PubMed] [Google Scholar]
  • 113.Schlame M, Acehan D, Berno B, Xu Y, Valvo S, Ren M, Stokes DL, and Epand RM (2012). The physical state of lipid substrates provides transacylation specificity for tafazzin. Nat Chem Biol 8, 862–869. 10.1038/nchembio.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Luongo TS, Eller JM, Lu M-J, Niere M, Raith F, Perry C, Bornstein MR, Oliphint P, Wang L, McReynolds MR, et al. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. Nature 588, 174–179. 10.1038/s41586-020-2741-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.MCART1/SLC25A51 is required for mitochondrial NAD transport | Science Advances. https://www.science.org/doi/10.1126/sciadv.abe5310. [DOI] [PMC free article] [PubMed]
  • 116.Shen H, Campanello G, Flicker D, Grabarek Z, Hu J, Luo C, Banerjee R, and Mootha VK (2017). The human knockout gene CLYBL connects itaconate to vitamin B12. Cell 171, 771–782.e11. 10.1016/j.cell.2017.09.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Chen WW, Freinkman E, and Sabatini DM (2017). Rapid immunopurification of mitochondria for metabolite profiling and absolute quantification of matrix metabolites. Nat Protoc 12, 2215–2231. 10.1038/nprot.2017.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Fasimoye R, Dong W, Nirujogi RS, Rawat ES, Iguchi M, Nyame K, Phung TK, Bagnoli E, Prescott A, Alessi DR, et al. (2022). Golgi-IP, a novel tool for multimodal analysis of Golgi molecular content. 2022.11.22.517583. 10.1101/2022.11.22.517583. [DOI] [PMC free article] [PubMed]
  • 119.Adelmann CH, Traunbauer AK, Chen B, Condon KJ, Chan SH, Kunchok T, Lewis CA, and Sabatini DM (2020). MFSD12 mediates the import of cysteine into melanosomes and lysosomes. Nature 588, 699–704. 10.1038/s41586-020-2937-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Allen FM, Costa ASH, Gruszczyk AV, Bates GR, Prag HA, Nikitopoulou E, Viscomi C, Frezza C, James AM, and Murphy MP (2023). Rapid fractionation of mitochondria from mouse liver and heart reveals in vivo metabolite compartmentation. FEBS Letters 597, 246–261. 10.1002/1873-3468.14511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Qin W, Cho KF, Cavanagh PE, and Ting AY (2021). Deciphering molecular interactions by proximity labeling. Nat Methods 18, 133–143. 10.1038/s41592-020-01010-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Hananya N, Ye X, Koren S, and Muir TW (2022). A genetically encoded photo-proximity labeling approach for mapping protein territories. 2022.07.30.502153. 10.1101/2022.07.30.502153. [DOI] [PMC free article] [PubMed]
  • 123.Yan T, Julio AR, Villaneuva M, Jones AE, Ball AB, Boatner LM, Turmon AC, Yen SL, Desai HS, Divakaruni AS, et al. (2023). Proximity-labeling chemoproteomics defines the subcellular cysteinome and inflammation-responsive mitochondrial redoxome. 2023.01.22.525042. 10.1101/2023.01.22.525042. [DOI] [PMC free article] [PubMed]
  • 124.Cho KF, Branon TC, Rajeev S, Svinkina T, Udeshi ND, Thoudam T, Kwak C, Rhee H-W, Lee I-K, Carr SA, et al. (2020). Split-TurboID enables contact-dependent proximity labeling in cells. Proceedings of the National Academy of Sciences 117, 12143–12154. 10.1073/pnas.1919528117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Hicks KG, Cluntun AA, Schubert HL, Hackett SR, Berg JA, Leonard PG, Aleixo MAA, Blevins A, Barta P, Tilley S, et al. (2021). Protein-Metabolite Interactomics Reveals Novel Regulation of Carbohydrate Metabolism. 2021.08.28.458030. 10.1101/2021.08.28.458030. [DOI]
  • 126.Van Vranken JG, Li J, Mitchell DC, Navarrete-Perea J, and Gygi SP (2021). Assessing target engagement using proteome-wide solvent shift assays. eLife 10, e70784. 10.7554/eLife.70784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Gaetani M, Sabatier P, Saei AA, Beusch CM, Yang Z, Lundström SL, and Zubarev RA (2019). Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution. J. Proteome Res 18, 4027–4037. 10.1021/acs.jproteome.9b00500. [DOI] [PubMed] [Google Scholar]
  • 128.Piazza I, Kochanowski K, Cappelletti V, Fuhrer T, Noor E, Sauer U, and Picotti P. (2018). A Map of Protein-Metabolite Interactions Reveals Principles of Chemical Communication. Cell 172, 358–372.e23. 10.1016/j.cell.2017.12.006. [DOI] [PubMed] [Google Scholar]
  • 129.Paradkar PN, Zumbrennen KB, Paw BH, Ward DM, and Kaplan J. (2009). Regulation of Mitochondrial Iron Import through Differential Turnover of Mitoferrin 1 and Mitoferrin 2. Molecular and Cellular Biology 29, 1007–1016. 10.1128/MCB.01685-08. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES